electroCore Inc.
ECOR | NASDAQ
$12.57
+$0.58 (+4.79%)
Sep 22, 2026, 11:45 AM ET · Market open
+4.79%
(1D)Rating
Updated: Sep 1, 2026Key Statistics
Market Data
Market Cap $113.37M
1D Range
11.99 12.70
52W Range
4.41 12.70
Valuation (TTM)
PE -7.05
PB -38.76
EV/EBITDA -8.61
Valuation (NTM)
Forward PE 78.80
Forward PEG 0.13
Price Target $18
Cash Flow
FCF Yield -11.8%
SBC Adj. FCF Yield -15.2%
SBC Impact -29.1%
Margins
Gross Margin 87.1%
Operating Margin -37.6%
FCF Margin -34.5%
Growth (CAGR)
Revenue 3Y | 5Y 50.4% |
52.5%
Dil EPS 3Y | 5Y 13.5% |
27.8%
FCF 3Y | 5Y -13.9% |
12.8%
Returns
ROA -86.6%
ROE 524.7%
ROIC -201.7%
Financial Health
Net Cash
$481K
Current Ratio 1.21
Interest Coverage -11.88
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, t...
Sector Healthcare
Industry Medical - Devices
Employees 83
IPO Date Jun 21, 2018
Website www.electrocore.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$18
Upside
+43.20%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ECOR